`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` Paper No. ____
`
`Filed: May 13, 2015
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`__________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`LUPIN LTD. and LUPIN PHARMACEUTICALS INC.
`Petitioners
`v.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` SENJU PHARMACEUTICAL CO., LTD.
`Patent Owner
`_________________
`Case IPR2015-01097
`U.S. Patent 8,754,131
`_________________
`
`PATENT OWNER’S MANDATORY NOTICES
` PURSUANT TO 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2015-01097
`U.S. Patent 8,754,131
`Pursuant to 37 C.F.R. § 42.8(a)(2), Patent Owner Senju Pharmaceutical Co.,
`
`Ltd. (“Senju”) hereby submits the following mandatory notices in connection with
`
`this proceeding.
`
`I.
`
`SENJU’S POWER OF ATTORNEY
`
`A Power of Attorney appointing lead and back-up counsel is being filed
`
`concurrently with these Notices.
`
`II.
`
`SENJU’S MANDATORY NOTICES
`
`(a) 37 C.F.R. § 42.8(b)(1): Real Party-in-Interest
`
`The real party-in-interest for the Patent Owner is Senju Pharmaceutical Co.,
`
`Ltd. Other real parties-in-interest include Bausch & Lomb, Inc., and Bausch & Lomb
`
`Pharma Holdings Corp.
`
`(b) Related Matters
`
`1. Judicial
`
`
`
`The patent challenged here, U.S. Patent 8,754,131 (“the ‘131 patent”), has been
`
`asserted in the following litigations:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`
`
`Case Caption
`Senju Pharm. Co. Ltd., Bausch & Lomb, Inc. and Bausch &
`Lomb Pharma Holdings Corp. v. Lupin, Ltd. and Lupin
`Pharms., Inc.
`Senju Pharm. Co., Ltd., Bausch & Lomb, Inc. and Bausch &
`Lomb Pharma Holdings Corp. v. Metrics, Inc., Coastal
`Pharms., Inc., Mayne Pharma Group Ltd., and Mayne
`Pharma (USA), Inc.
`Senju Pharm. Co., Ltd., Bausch & Lomb, Inc. and Bausch &
`Lomb Pharma Holdings Corp. v. Metrics, Inc., Coastal
`Pharms., Inc., Mayne Pharma Group Ltd., and Mayne
`Pharma (USA), Inc.
`Senju Pharm. Co., Ltd., Bausch & Lomb, Inc. and Bausch &
`Lomb Pharma Holdings Corp. v. Metrics, Inc., Coastal
`Pharms., Inc., Mayne Pharma Group Ltd., and Mayne
`Pharma (USA), Inc.
`Senju Pharm. Co., Ltd., Bausch & Lomb, Inc. and Bausch &
`Lomb Pharma Holdings Corp. v. Innopharma Licensing, Inc.,
`Innopharma Licensing, LLC, Innopharma, Inc., and
`Innopharma LLC
`Senju Pharm. Co. Ltd., Bausch & Lomb Inc. and Bausch &
`Lomb Pharma Holdings Corp. v. Apotex Inc. and Apotex
`Corp.
`Senju Pharm. Co. Ltd., Bausch & Lomb Inc. and Bausch &
`Lomb Pharma Holdings Corp. v. Paddock Laboratories, LLC,
`L. Perrigo Co., and Perrigo Co.
`Senju Pharmaceutical Co. Ltd., Bausch & Lomb Inc. and
`Bausch & Lomb Pharma Holdings Corp. v. Paddock Labs.,
`LLC, L. Perrigo Company, and Perrigo Co.
`Senju Pharm. Co. Ltd., Bausch & Lomb Inc. and Bausch &
`Lomb Pharma Holdings Corp. v. InnoPharma Licensing, Inc.,
`Innopharma Licensing, LLC, Innopharma, Inc., Innopharma,
`LLC, Mylan Pharms., Inc., and Mylan Inc.
`
`Case IPR2015-01097
`U.S. Patent 8,754,131
`Case
`Filing
`Number Court
`Date
`1:14-
`Aug.
`cv-
`15,
`05144
`2014
`1:14-
`June
`cv-
`20,
`03962
`2014
`
`D.N.J.
`
`D.N.J.
`
`1:14-
`cv-
`04964
`
`4:14-
`cv-
`00141
`
`1:14-
`cv-
`06893
`1:15-
`cv-
`00336
`1:15-
`cv-
`00337
`1:15-
`cv-
`00087
`1:15-
`cv-
`03240
`
`D.N.J. Aug. 7,
`2014
`
`E.D.N
`.C.
`
`Aug. 8,
`2014
`
`D.N.J. Nov. 3,
`2014
`
`D.N.J.
`
`D.N.J.
`
`D.Del.
`
`Jan. 16,
`2015
`
`Jan. 16,
`2015
`
`Jan. 26,
`2015
`
`D.N.J. May 8,
`2015
`
`
`There are four other related patents currently involved in parallel district court
`
`proceedings, U.S. Patents Nos. 8,129,431 (“the ‘431 patent”), 8,669,290 (“the ‘290
`
`patent”), 8,871,813 (“the ‘813 patent”) and 8,927,606 (“the ‘606 patent”). As the
`
`
`
`3
`
`
`
`Case IPR2015-01097
`U.S. Patent 8,754,131
`Patent Owner reads 37 C.F.R. § 42.8, Patent Owner is not required to individually
`
`identify these proceedings, but if the Board prefers them identified, Patent Owner will
`
`do so.
`
`2. Administrative
`
`Petitioner filed concurrently with this petition three other petitions for inter
`
`partes review: (1) IPR2015-01099 of the ’290 patent, (2) IPR2015-01105 of the ‘813
`
`patent, and (3) IPR2015-01100 of the ‘606 patent. Patent Owner additionally notes
`
`the existence of pending U.S. Applications Serial Nos. 14/261,720 and 14/269,692,
`
`which ultimately claim benefit to the application that issued as the ’431 patent. Patent
`
`Owner identifies two additional administrative matters related to this patent family:
`
`8,129,431
`
`IPR2014-
`01043
`
`8,669,290
`
`IPR No. Patent Filed
`June
`IPR2014-
`26,
`01041
`2014
`June
`26,
`2014
`Mar.
`19,
`2015
`
`IPR2015-
`00903
`
`8,129,431
`
`IPR2015-
`00902
`
`8,669,290
`
`Mar.
`19,
`2015
`
`Case Caption
`Metrics, Inc. v. Mayne Pharma, and Johnson Matthey, Inc. v.
`Senju Pharm. Co., Ltd, Bausch & Lomb, Inc., and Bausch
`& Lomb Pharma Holdings Corp.
`Metrics, Inc. v. Mayne Pharma, and Johnson Matthey, Inc. v.
`Senju Pharm. Co., Ltd, Bausch & Lomb, Inc., and Bausch
`& Lomb Pharma Holdings Corp.
`Innopharma Licensing, Inc., Innopharma Licensing, LLC,
`Innopharma, Inc., Innopharma LLC, Mylan Pharmaceuticals
`Inc., and Mylan Inc. v. Senju Pharm. Co., Ltd, Bausch &
`Lomb, Inc., and Bausch & Lomb Pharma Holdings Corp.
`Innopharma Licensing, Inc., Innopharma Licensing, LLC,
`Innopharma, Inc., Innopharma LLC, Mylan Pharmaceuticals
`Inc., and Mylan Inc. v. Senju Pharm. Co., Ltd, Bausch &
`Lomb, Inc., and Bausch & Lomb Pharma Holdings Corp.
`
`
`
`
`
`
`
`
`
`4
`
`
`
`Case IPR2015-01097
`U.S. Patent 8,754,131
`(b) 37 C.F.R. § 42.8(b)(3) and (4): Lead and Back-Up Counsel, and
`Service Information
`
`Senju designates the following counsel to transact all business in the United
`
`States Patent & Trademark Office associated with the above-captioned proceeding.
`
`Lead Counsel
`Bryan C. Diner
`(Reg. No. 32,409)
`Finnegan, Henderson, Farabow,
`
`Garrett & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Phone: (202) 408-4116
`Fax: (202) 408-4400
`Email: Bryan.Diner@finnegan.com
`
`
`
`
`
`
`
`
`Back-Up Counsel
`M. Andrew Holtman
`(Reg. No. 53,032)
`Finnegan, Henderson, Farabow,
`
`Garrett & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Phone: (202) 408-4131
`Fax: (202) 408-4400
`Email: Andy.Holtman@finnegan.com
`
`Justin J. Hasford
`(Reg. No. 62,180)
`Finnegan, Henderson, Farabow,
`
`Garrett & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Phone: (202) 408-4175
`Fax: (202) 408-4400
`Email: Justin.Hasford@finnegan.com
`
`Jonathan Stroud
`(Reg. No. 72,518)
`Finnegan, Henderson, Farabow,
`
`Garrett & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Phone: (202) 408-4469
`Fax: (202) 408-4400
`Email: Jonathan.Stroud@finnegan.com
`
`5
`
`
`
`Case IPR2015-01097
`U.S. Patent 8,754,131
`Please address all correspondence regarding this proceeding to lead and back-
`
`up counsel. Senju also consents to electronic service by email.
`
`
`
`Dated: May 13, 2015
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`By: /Jonathan R. K. Stroud/
`Bryan C. Diner, Lead Counsel
`Reg. No. 32,409
`M. Andrew Holtman, Back-up Counsel
`Reg. No. 53,032
`Justin J. Hasford, Back-up Counsel
`Reg. No. 62,180
`Jonathan Stroud, Back-up Counsel
`Reg. No. 72,518
`Finnegan, Henderson, Farabow, Garrett
` & Dunner, L.L.P.
`901 New York Ave. NW
`Washington, DC 20001-4413
`(202) 408-4000
`
`Counsel for Patent Owner
`
`6
`
`
`
`Case IPR2015-01097
`U.S. Patent 8,669,290
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent Owner’s
`
`Mandatory Notices was served on May 13, 2015, via email directed to counsel of
`
`record for the Petitioner at the following:
`
`Deborah Yellin
`DYellin@crowell.com
`
`Jonathan Lindsay
`JLindsay@crowell.com
`
`
`Date: May 13, 2015
`
`/Ashley F. Cheung/
`Ashley F. Cheung
`Case Manager
`
`Finnegan, Henderson, Farabow, Garrett &
`Dunner, LLP
`
`
`
`7
`
`
`
`
`
`